Company page
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. is a public company traded under the ticker ELOX in the American market. The company has a market capitalization of approximately $1.19 million. Eloxx focuses on developing therapies for genetic diseases, particularly those caused by nonsense mutations.
- Ticker
- ELOX:OTC
- Asset type
- Stock
- Market cap
- $1.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD